Ryou Nishikawa

  • Citations Per Year
Learn More
TPS136 Background: Despite therapeutic advances in standard of care (SOC), glioblastoma (GBM) remains a devastating disease with a dismal prognosis. In patients with recurrent GBM, bevacizumab (BEV) has demonstrated activity, as measured by objective response rate (ORR) and 6-month progression free survival (PFS), compared with historical controls. The(More)
Chondroblastoma of the skull is a rare tumor and only 54 cases have been reported to date. A case of chondroblastoma arising from the squamous part of the left temporal bone is reported. A 34-year-old woman had 6-month history of left conductive hearing disturbance and tenderness in the left temporal region. Plain skull X-ray showed a well demarcated(More)
An eleven-month-old male infant with an ependymal cyst is reported. He was born after full-term pregnancy and vacuum extraction. His growth and development was somewhat retarded and he could control his head at the age of five months. He was admitted to our hospital because of the enlargement of his head and the paretic right upper limb. On admission he was(More)
We reported a 66-year-old right-handed man, in whom developmental stuttering had almost been cured previously, who suffered a brain tumor. He developed not only left hemiparesis but also speech dysfluency such as acquired stuttering and aphasia. MRI showed a brain tumor in the body of the corpus callosum. The main feature of his stuttering was repetition of(More)
  • 1